Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Pfizer has acquired Amplyx Pharmaceuticals, a San Diego, California-based biopharmaceutical company developing therapies for people with compromised immune systems susceptible to fungal infections. Financial terms were not disclosed. Amplyx’s lead...

Merck & Co. has announced goals to achieve carbon neutrality across its operations by 2025 and a 30% reduction in its value-chain emissions by 2030. Merck says it will achieve carbon neutrality by increasing efficiency, reducing carbon...

Johnson & Johnson (J&J) has provided updates on the manufacturing of its COVID-19 vaccine as well as on its rollout in the US and Europe.   On the manufacturing front, J&J reported that it is working closely with the US...

Bristol-Myers Squibb (BMS) has announced plans for a new cell-therapy manufacturing site in Leiden, the Netherlands. Planning for site design and development is underway with construction slated to begin later this year (2021). Leiden will be BMS’...

Johnson & Johnson (J&J) has provided an update regarding a pause of use of its COVID-19 vaccine. Earlier this week (as reported on April 15, 2021), the US Food and Drug Administration (FDA) and the US Centers for Disease Control and...

Patrizia Cavazzoni, M.D., has been appointed as Director of the US Food and Drug Administration’s Center for Drug Evaluation and Research (CDER). She has served as Acting Director for the past year. She succeeds Janet Woodcock, M.D., now Acting...

Sanofi plans to invest EUR 400 million ($477 million) over five years to create a vaccine-production site in Singapore. In partnership with the Singapore Economic Development Board, the new site will mainly supply the Asian region and complement...